IL89031A - Drugs containing benzamide for the treatment of thought disorders or for their prevention and preparation - Google Patents
Drugs containing benzamide for the treatment of thought disorders or for their prevention and preparationInfo
- Publication number
- IL89031A IL89031A IL8903189A IL8903189A IL89031A IL 89031 A IL89031 A IL 89031A IL 8903189 A IL8903189 A IL 8903189A IL 8903189 A IL8903189 A IL 8903189A IL 89031 A IL89031 A IL 89031A
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- dementia
- moclobemide
- cognitive
- prevention
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH29888 | 1988-01-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
IL89031A0 IL89031A0 (en) | 1989-08-15 |
IL89031A true IL89031A (en) | 1995-07-31 |
Family
ID=4183804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL8903189A IL89031A (en) | 1988-01-28 | 1989-01-23 | Drugs containing benzamide for the treatment of thought disorders or for their prevention and preparation |
Country Status (15)
Country | Link |
---|---|
US (1) | US4906626A (fr) |
EP (1) | EP0326023B1 (fr) |
JP (1) | JPH07116043B2 (fr) |
KR (1) | KR960016203B1 (fr) |
AT (1) | ATE113207T1 (fr) |
AU (1) | AU620584B2 (fr) |
CA (1) | CA1332151C (fr) |
DE (1) | DE58908544D1 (fr) |
DK (1) | DK171094B1 (fr) |
ES (1) | ES2063060T3 (fr) |
HU (1) | HU203042B (fr) |
IE (1) | IE65409B1 (fr) |
IL (1) | IL89031A (fr) |
PH (1) | PH26030A (fr) |
ZA (1) | ZA89523B (fr) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0559297B1 (fr) * | 1986-12-17 | 1997-05-07 | Glaxo Group Limited | Utilisation des dérivés hétérocycliques pour la manufacture des médicaments |
FR2645742A1 (fr) * | 1989-04-12 | 1990-10-19 | Delagrange Laboratoires | Application de derives de 2-methoxy 4-(4,5-dihydro 2-imidazolyl (ou 2-oxazolyl) amino) 5-chloro benzamide dans le traitement des troubles de la fonction cognitive |
JP3172202B2 (ja) * | 1990-11-29 | 2001-06-04 | エフ.ホフマン−ラ ロシュ アーゲー | 不安の障害の処置剤 |
US6951884B2 (en) * | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
AU2004283452A1 (en) * | 2003-10-23 | 2005-05-06 | F. Hoffmann-La Roche Ag | Benzazepine derivatives as MAO-B inhibitors |
WO2005053703A1 (fr) * | 2003-12-02 | 2005-06-16 | Leslie James Sheldon | Polytherapie contre la demence, la depression et l'apathie |
CA2628074C (fr) | 2005-10-25 | 2014-01-14 | Shionogi & Co., Ltd. | Derive aminodihydrothiazine |
WO2008133273A1 (fr) * | 2007-04-24 | 2008-11-06 | Shionogi & Co., Ltd. | Composition pharmaceutique pour le traitement de la maladie d'alzheimer |
KR20100017255A (ko) * | 2007-04-24 | 2010-02-16 | 시오노기 앤드 컴파니, 리미티드 | 환식기로 치환된 아미노다이하이드로싸이아진 유도체 |
US8637504B2 (en) | 2008-06-13 | 2014-01-28 | Shionogi & Co., Ltd. | Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
US8703785B2 (en) * | 2008-10-22 | 2014-04-22 | Shionogi & Co., Ltd. | 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
US8999980B2 (en) | 2009-12-11 | 2015-04-07 | Shionogi & Co., Ltd. | Oxazine derivatives |
JP5766198B2 (ja) | 2010-10-29 | 2015-08-19 | 塩野義製薬株式会社 | 縮合アミノジヒドロピリミジン誘導体 |
EP2634186A4 (fr) | 2010-10-29 | 2014-03-26 | Shionogi & Co | Dérivé de naphtyridine |
EP2703399A4 (fr) | 2011-04-26 | 2014-10-15 | Shionogi & Co | Dérivé d'oxazine et inhibiteur de bace 1 le contenant |
WO2014065434A1 (fr) | 2012-10-24 | 2014-05-01 | Shionogi & Co., Ltd. | Dérivés de dihydrooxazine ou d'oxazépine ayant une activité inhibitrice de bace1 |
US10599006B2 (en) | 2016-04-12 | 2020-03-24 | E-Vision Smart Optics, Inc. | Electro-active lenses with raised resistive bridges |
ES2973138T3 (es) | 2016-04-12 | 2024-06-18 | E Vision Smart Optics Inc | Lentes electroactivas con puentes resistivos elevados |
-
1989
- 1989-01-11 CA CA000587927A patent/CA1332151C/fr not_active Expired - Lifetime
- 1989-01-13 US US07/297,168 patent/US4906626A/en not_active Expired - Lifetime
- 1989-01-19 EP EP89100901A patent/EP0326023B1/fr not_active Expired - Lifetime
- 1989-01-19 AT AT89100901T patent/ATE113207T1/de not_active IP Right Cessation
- 1989-01-19 DE DE58908544T patent/DE58908544D1/de not_active Expired - Lifetime
- 1989-01-19 ES ES89100901T patent/ES2063060T3/es not_active Expired - Lifetime
- 1989-01-23 ZA ZA89523A patent/ZA89523B/xx unknown
- 1989-01-23 IL IL8903189A patent/IL89031A/en unknown
- 1989-01-25 HU HU89303A patent/HU203042B/hu unknown
- 1989-01-25 JP JP1014249A patent/JPH07116043B2/ja not_active Expired - Lifetime
- 1989-01-27 KR KR1019890000867A patent/KR960016203B1/ko not_active IP Right Cessation
- 1989-01-27 IE IE27389A patent/IE65409B1/en not_active IP Right Cessation
- 1989-01-27 PH PH38119A patent/PH26030A/en unknown
- 1989-01-27 AU AU28836/89A patent/AU620584B2/en not_active Expired
- 1989-01-27 DK DK036889A patent/DK171094B1/da not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DK36889D0 (da) | 1989-01-27 |
DK171094B1 (da) | 1996-06-03 |
JPH01224318A (ja) | 1989-09-07 |
DE58908544D1 (de) | 1994-12-01 |
HUT50042A (en) | 1989-12-28 |
CA1332151C (fr) | 1994-09-27 |
JPH07116043B2 (ja) | 1995-12-13 |
KR960016203B1 (ko) | 1996-12-06 |
PH26030A (en) | 1992-01-29 |
AU620584B2 (en) | 1992-02-20 |
US4906626A (en) | 1990-03-06 |
DK36889A (da) | 1989-07-29 |
AU2883689A (en) | 1989-08-03 |
EP0326023A2 (fr) | 1989-08-02 |
EP0326023A3 (en) | 1990-09-05 |
HU203042B (en) | 1991-05-28 |
IE890273L (en) | 1989-07-28 |
ES2063060T3 (es) | 1995-01-01 |
ZA89523B (en) | 1989-09-27 |
IL89031A0 (en) | 1989-08-15 |
EP0326023B1 (fr) | 1994-10-26 |
IE65409B1 (en) | 1995-10-18 |
ATE113207T1 (de) | 1994-11-15 |
KR890011589A (ko) | 1989-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4906626A (en) | Method of use for treatment or prevention of cognitive disorders | |
RU2334514C1 (ru) | СРЕДСТВО ДЛЯ УЛУЧШЕНИЯ КОГНИТИВНЫХ ФУНКЦИЙ И ПАМЯТИ НА ОСНОВЕ ГИДРИРОВАННЫХ ПИРИДО (4,3-b) ИНДОЛОВ (ВАРИАНТЫ), ФАРМАКОЛОГИЧЕСКОЕ СРЕДСТВО НА ЕГО ОСНОВЕ И СПОСОБ ЕГО ПРИМЕНЕНИЯ | |
JPS591412A (ja) | 脳血管不全症処置用固形製剤 | |
CN109846884A (zh) | 用tor激酶抑制剂治疗癌症 | |
TWI549678B (zh) | 4-胺基吡啶於改善具有脫髓鞘及其他神經系統狀況之患者的神經認知及/或神經精神缺陷之用途 | |
CN104884053B (zh) | 用于改善记忆表现的益智组合物 | |
DK169656B1 (da) | Anvendelse af adenosinderivater til fremstilling af et lægemiddel med virkning mod demens | |
Towse | Cinnarizine—a labyrinthine sedative | |
US3459850A (en) | Sustained-release tablets,a process and a composition for their preparation | |
MXPA05009850A (es) | Metodo para tratar el deterioro cognitivo leve y para prevenir o atrasar la enfermedad de alzheimer. | |
Boner et al. | Efficacy and safety of loratadine suspension in the treatment of children with allergic rhinitis | |
JPH04327532A (ja) | 活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤 | |
US4719212A (en) | Therapeutic agent for memory disturbance | |
NZ188098A (en) | Antithrombotic compositions based on synergistic combinations of 2,6-bis-(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine and 1,2-diphenyl-4-(2-phenylsulphinylethyl)pyrazolidine-3,5-dione | |
Miyamoto et al. | Effects of a sustained release formulation of thyrotropin-releasing hormone on behavioral abnormalities in senescence-accelerated mice | |
CA1201656A (fr) | Produits pharmaceutiques, leur composition et leur emploi | |
US3740433A (en) | Anti-anxiety composition and method of use | |
US4315937A (en) | Ergots and their use in treating minimal brain dysfunction | |
RU2277096C2 (ru) | Средства против слабоумия, содержащие производное 2-арил-8-оксодигидропурина в качестве активного ингредиента | |
AU634149B2 (en) | Pain-killer | |
US11752141B2 (en) | Pharmaceutical compositions and methods utilizing neostigmine and an NK-1 antagonist for treating myasthenia gravis | |
JPWO2012036191A1 (ja) | 脳機能改善用組成物および脳機能を改善する方法 | |
Costall et al. | 5-HT3 receptor antagonists in the treatment of cognitive disorders | |
Toma et al. | Incidence of Yersinia enterocolitica and Y. pseudotuberculosis infections in Canada; 1975 semiannual report. | |
AU4279599A (en) | Use of an nk-1 receptor antagonist for treating cognitive disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed | ||
KB | Patent renewed |